Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 4 1 Phase 3 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Weight Loss 2 Stomach Neoplasms 2 Malnutrition 2 Esophageal Neoplasms 2 Pituitary Neoplasms 1 Periampullary Tumors 1 Pancreatic Neuroendocrine Tumor G2 1 Pancreatic Neoplasms 1 Lymphocele 1 Endocrine System Diseases 1 Duodenal Neoplasms 1 Breast Neoplasms 1 Acromegaly 1

Interventions

Exercise 112 Surveys and Questionnaires 56 Early Intervention, Educational 49 Standard of Care 46 Methods 46 Magnetic Resonance Spectroscopy 45 Blood Specimen Collection 44 Acupuncture Therapy 44 Educational Status 43 Radiotherapy 36 Mammography 36 Control Groups 31 Therapeutics 29 Counseling 29 Psychiatric Rehabilitation 27 Cyclophosphamide 27 Sentinel Lymph Node Biopsy 25 Biopsy 24 Yoga 20 Mastectomy, Segmental 20 Resistance Training 19 Palliative Care 18 Neoadjuvant Therapy 18 High-Energy Shock Waves 18 Doxorubicin 18 Cognitive Behavioral Therapy 18 Magnetic Resonance Imaging 17 Practice Guidelines as Topic 16 Paclitaxel 16 Trastuzumab 15

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Breast Neoplasms × Octreotide × Clear all

NCT03791736 2022-07-28

SANDOSTATINE

Institut Cancerologie de l'Ouest

Phase NA Terminated

Breast Neoplasms, Lymphocele

Data powered by HemOnc (CC BY 4.0) Colophon ⚡